Review of health economic analyses in atopic dermatitis: how diverse is the literature?
Standard
Review of health economic analyses in atopic dermatitis: how diverse is the literature? / Gutknecht, Mandy; Reinert, Rabea; Augustin, Matthias.
in: EXPERT REV PHARM OUT, Jahrgang 19, Nr. 2, 04.2019, S. 127-145.Publikationen: SCORING: Beitrag in Fachzeitschrift/Zeitung › SCORING: Review › Forschung
Harvard
APA
Vancouver
Bibtex
}
RIS
TY - JOUR
T1 - Review of health economic analyses in atopic dermatitis: how diverse is the literature?
AU - Gutknecht, Mandy
AU - Reinert, Rabea
AU - Augustin, Matthias
PY - 2019/4
Y1 - 2019/4
N2 - INTRODUCTION: Atopic dermatitis (AD) is a common chronic, pruritic inflammatory skin disease. It is associated with a high personal burden of illness and economic consequences. Since AD can occur at any age, and many treatments and prevention options exist, a high diversity of health economic findings can be expected. Areas covered: A literature search was performed in January 2018 with the objective to report on previously published health economic analyses in AD. In total, 89 analyses were identified. Most analyses focused on the cost-of-illness (n = 34; 38%) followed by cost-utility and/or cost-effectiveness evaluations (n = 26; 29%) and cost analyses (n = 12; 13%) of treatments in AD. Further evaluations dealt with the prevention of AD (n = 13; 15%). Besides the different methods of health economic analyses, high variety was identified concerning the target population, comprised costs, effectiveness measures, comparators, and the modeling method. Expert commentary: Given the different health-care environments and methodologies chosen, health economic analyses in AD cannot be compared with each other and cannot be related to other landscapes of care. Nevertheless, the analyses identified give hint for a high socioeconomic impact of AD on the one hand and unmet needs from the patient perspective on the other.
AB - INTRODUCTION: Atopic dermatitis (AD) is a common chronic, pruritic inflammatory skin disease. It is associated with a high personal burden of illness and economic consequences. Since AD can occur at any age, and many treatments and prevention options exist, a high diversity of health economic findings can be expected. Areas covered: A literature search was performed in January 2018 with the objective to report on previously published health economic analyses in AD. In total, 89 analyses were identified. Most analyses focused on the cost-of-illness (n = 34; 38%) followed by cost-utility and/or cost-effectiveness evaluations (n = 26; 29%) and cost analyses (n = 12; 13%) of treatments in AD. Further evaluations dealt with the prevention of AD (n = 13; 15%). Besides the different methods of health economic analyses, high variety was identified concerning the target population, comprised costs, effectiveness measures, comparators, and the modeling method. Expert commentary: Given the different health-care environments and methodologies chosen, health economic analyses in AD cannot be compared with each other and cannot be related to other landscapes of care. Nevertheless, the analyses identified give hint for a high socioeconomic impact of AD on the one hand and unmet needs from the patient perspective on the other.
KW - Journal Article
KW - Dermatitis, Atopic/economics
KW - Economics, Medical
KW - Health Services Needs and Demand
KW - Health Care Costs
KW - Cost-Benefit Analysis
KW - Humans
KW - Cost of Illness
KW - Models, Economic
U2 - 10.1080/14737167.2019.1549491
DO - 10.1080/14737167.2019.1549491
M3 - SCORING: Review article
C2 - 30590976
VL - 19
SP - 127
EP - 145
JO - EXPERT REV PHARM OUT
JF - EXPERT REV PHARM OUT
SN - 1473-7167
IS - 2
ER -